Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MLLCF MOLECULAR PARTNERS AG

5.969
-0.151-2.47%
Trading Session 09/28 15:03 ET
High
5.969
Open
5.880
Turnover
10.05K
Low
5.880
Pre Close
6.120
Volume
1.70K
Market Cap
194.08M
P/E(TTM)
1.61
52wk High
32.000
Shares
32.51M
P/E(Static)
Loss
52wk Low
5.160
Float Cap
183.68M
Bid/Ask %
0.00%
Historical High
32.000
Shs Float
30.77M
Volume Ratio
23.52
Historical Low
5.160
Dividend TTM
--
Div Yield TTM
--
P/B
0.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
1.46%
Avg Price
5.911
Lot Size
1
Float Cap
183.68M
Bid/Ask %
0.00%
Historical High
32.000
Shs Float
30.77M
Volume Ratio
23.52
Historical Low
5.160
Dividend TTM
--
P/B
0.72
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
1.46%
Avg Price
5.911
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.
CEO: Dr. Patrick Amstutz, PhD
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...